Universal Display Corporation — Q3 2020 Form 10-Q Summary
Business Context and Reporting Period
Universal Display develops, licenses and commercializes OLED technologies and materials for display and lighting applications. Revenue is primarily generated from OLED material sales, intellectual-property licensing and royalties, technology development and support, and Adesis contract research services. The filing covers the three and nine months ended September 30, 2020, compared with the corresponding 2019 periods.
OLED material sales represented 97% of revenue in the third quarter and 96% for the nine-month period. Approximately 97% of quarterly revenue and 96% of nine-month revenue came from outside North America. In June 2020, the company formed OVJP Corporation to advance commercialization of its Organic Vapor Jet Printing technology.
Financial Performance and Liquidity
| Metric | Q3 2020 | Q3 2019 | 9M 2020 | 9M 2019 |
|---|---|---|---|---|
| Revenue | $117.1 million | $97.5 million | $287.3 million | $303.4 million |
| Gross margin | $93.7 million | $80.2 million | $228.8 million | $246.3 million |
| Gross margin percentage | 80% | 82% | 80% | 81% |
| Operating income | $48.4 million | $40.8 million | $91.7 million | $123.9 million |
| Net income | $40.5 million | $37.0 million | $79.5 million | $111.9 million |
| Diluted EPS | $0.85 | $0.78 | $1.67 | $2.36 |
| Operating cash flow | Not separately provided | Not separately provided | $75.8 million | $137.7 million |
Third-quarter revenue increased 20.1% year over year, while net income increased 9.6%. Nine-month revenue declined 5.3%, operating income declined 25.9%, and net income declined 29.0%. The quarterly operating margin was approximately 41.4%, compared with 41.9% in the prior-year quarter; the nine-month operating margin was approximately 31.9%, compared with 40.8%.
At September 30, 2020, cash and cash equivalents were $162.6 million and short-term investments were $510.0 million, totaling $672.7 million versus $646.1 million at December 31, 2019. Working capital was $703.4 million. The company reported no debt in the disclosed balance-sheet liabilities and stated that it expects available liquidity to satisfy obligations for at least the next 12 months.
Capital expenditures for property and equipment were $19.2 million during the first nine months. Financing cash outflows included $21.3 million of dividends and $14.3 million of employee stock-compensation tax withholdings. The board declared an additional $0.15 per-share dividend payable December 31, 2020.
Material Changes Versus the Prior Comparable Period
- Q3 revenue benefited from stronger OLED display-market demand and returned to pre-COVID-19 levels after weaker demand in the second quarter.
- Nine-month revenue remained below 2019 because of COVID-19-related weakness in emitter demand during the quarter ended June 30, 2020.
- Gross margin percentage declined to 80% from 82% in Q3 and to 80% from 81% for the nine-month period, reflecting higher manufacturing costs and product mix.
- Research and development expense rose 24.0% in Q3 and 19.9% for the nine-month period, primarily from higher employee compensation and operating costs, including increased contract research activity.
- Stock-based compensation increased materially, contributing to higher operating expenses.
- Interest income declined because of lower yields on available-for-sale investments.
- Operating cash flow fell $61.9 million year over year, primarily reflecting lower net income and working-capital effects, although deferred-revenue collections remained a significant source of cash.
- Inventory increased to $84.1 million from $64.0 million at year-end 2019. The company recorded an $808,000 inventory reserve increase during the first nine months, compared with $4.2 million in the prior-year period.
Guidance, Outlook, Risks and Unusual Items
The filing does not provide formal revenue or earnings guidance. Management expects COVID-19 to continue adversely affecting operations, revenue, net income and cash flow at least through the balance of 2020, although the quarter ended September 30 showed stronger demand. Risks include renewed pandemic outbreaks, retail and customer disruptions, uncertain consumer demand, supply-chain and logistics interruptions, work-from-home productivity effects, and international trade restrictions.
Revenue recognition included a notable item: a previously constrained emitter shipment became recognizable in the first nine months after the customer’s March 15, 2020 return right expired without exercise. Deferred revenue was $190.0 million at September 30, 2020, and the company reported $13.8 million of committed phosphorescent-emitter backlog expected to be fulfilled within 90 days.
Customer concentration remains significant: three unidentified customers represented 41%, 28% and 14% of third-quarter revenue, respectively. Substantially all chemical materials were purchased from one supplier. Significant customer contracts generally expire in 2022.
The company is defending an opposition to European Patent No. 1390962 relating to white phosphorescent OLED technology. The matter was remanded for further consideration; management expects significant claims to be upheld but cannot assure the outcome. The company also has substantial uncertain tax positions involving Korean withholding taxes and related U.S. tax adjustments. A Korean District Court ruled in favor of UDC Ireland on one beneficial-ownership issue, but the Korean tax authority appealed.
Other commitments include $17.9 million of inventory purchase commitments, up to $7.6 million of remaining payments under the USC research agreement, and operating lease liabilities with a present value of $7.2 million. No off-balance-sheet arrangements were reported.
Important Facts for Investors to Verify
- Whether the Q3 recovery in OLED demand is sustainable amid COVID-19 and potential renewed disruptions.
- The effect of customer concentration and the expiration or renewal of major license and supply agreements in 2022.
- Future gross-margin performance as manufacturing costs, product mix and inventory levels change.
- The timing and ultimate outcome of Korean tax disputes, related refunds, and U.S. tax liabilities.
- The outcome and legal costs of the EP ’962 patent opposition and other patent challenges.
- The conversion of deferred revenue and backlog into future shipments and recognized revenue.
- Progress, investment requirements and commercialization prospects for OVJP technology.
- Whether liquidity remains sufficient if the pandemic materially reduces customer demand or disrupts supply chains.